Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects
about
Biomarkers of Renal Disease and Progression in Patients with DiabetesSynergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.Soluble TNF receptors and kidney dysfunction in the elderly.Response to comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetesThe predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetesCirculating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.Urine Albumin Excretion Is Associated with Cardiac Troponin T Detected with a Highly Sensitive Assay in a Community-Based Population.Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortFuture opportunities in diabetic retinopathy research.Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.Elevated Systemic Neutrophil Count Is Associated with Diabetic Macroalbuminuria among Elderly ChineseUremic Toxicity of Advanced Glycation End Products in CKD.Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.Comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes.Positive psychological characteristics in diabetes: a review.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Glucose targets for preventing diabetic kidney disease and its progression.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.High levels of soluble tumor necrosis factor receptors 1 and 2 and their association with mortality in patients undergoing hemodialysis.The effect of obesity and type 1 diabetes on renal function in children and adolescents.Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
P2860
Q26799505-04BEEDD0-8FB1-4466-93B5-813150C59BADQ30371076-E96EB90E-2537-4BDA-A75C-21E34E3422F2Q33660677-79E70F55-6424-433F-A149-1BE3D1C6BC28Q34278935-0D89C777-FC29-4D03-ABE8-2CE33920E664Q34606582-56F333F7-14DD-4154-B74E-47AE337631D0Q34682583-2968EEA6-C03C-4EF6-A8E6-9F82E474E4B9Q35591658-0FD26725-2A03-4075-8E64-43C9B9CBC5B4Q35692544-4AFDFD85-D525-430E-93FE-FF8E4D9144EEQ35753558-5662508D-8A7A-4FAA-BE1A-35C8E797CF4DQ35769521-03C2BEA0-7416-42C7-B489-03F523C30423Q35935835-AAB0E420-9559-4D38-B06C-C82096856751Q36325841-3E9CC90A-6654-4114-B79E-E11494A7B477Q36457226-8AA36EB1-24CD-4FA9-BDAE-DB0554B3E2A1Q36514906-C832F3A9-7350-4FF2-8128-A2B1289C2E91Q36562533-58A0A68B-66CE-4BA9-8915-1C28F0D5B6E4Q36629282-A68E00E8-E0E8-42D5-8E67-C77EB52396EEQ36723318-FA9EF284-66B3-4415-B93D-EDA65F8205ACQ37403183-09BE5CAE-78BE-4285-86A9-5FD49DD2C6A0Q37715550-31C6E31A-C428-4C06-8E87-0AF7E05FD0E2Q37715576-56889B9B-FE00-4C66-B8D8-D0DE87DFF5D8Q38139287-FE71C42A-C8EA-43BF-BC7C-49FBAA8D5D16Q38255902-14B31CD9-5E7D-4071-BE4B-916E7D449092Q38736800-DA65A0C5-7825-4CA9-AA85-3811B008B8C9Q38936622-D217E101-5B67-40B3-B2A9-75A210EE8B46Q39101016-E4AD335F-120D-4B38-B6BF-C1EF3081627BQ40528237-9BA3B464-ED38-49F3-A07C-39E089726B72Q42201543-FB4ECE0B-5CCF-4150-8FF4-739999187F20Q47423928-D5C483DE-7769-488C-99E6-EE0071108DB2
P2860
Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Baseline markers of inflammati ...... ia in type 1 diabetic subjects
@en
Baseline markers of inflammati ...... a in type 1 diabetic subjects.
@nl
type
label
Baseline markers of inflammati ...... ia in type 1 diabetic subjects
@en
Baseline markers of inflammati ...... a in type 1 diabetic subjects.
@nl
prefLabel
Baseline markers of inflammati ...... ia in type 1 diabetic subjects
@en
Baseline markers of inflammati ...... a in type 1 diabetic subjects.
@nl
P2093
P2860
P356
P1433
P1476
Baseline markers of inflammati ...... ia in type 1 diabetic subjects
@en
P2093
DCCT/EDIC Research Group
Gabriel Virella
Kelly J Hunt
Maria F Lopes-Virella
Nathaniel L Baker
Patricia A Cleary
Richard Klein
P2860
P304
P356
10.2337/DC12-2521
P407
P577
2013-03-20T00:00:00Z